


Searching News Database: omega-3
HSMN NewsFeed - 13 Sep 2017
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
HSMN NewsFeed - 6 May 2014
FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia
FDA Approves EPANOVA for the Treatment of Adults with Severe Hypertriglyceridemia
HSMN NewsFeed - 4 Feb 2014
Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales
Amarin Announces Promotion of Aaron Berg to Senior Vice President, Marketing and Sales
HSMN NewsFeed - 13 Dec 2011
Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing
Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing
HSMN NewsFeed - 8 Sep 2011
Catabasis Pharmaceuticals Appoints Joanne M. Donovan, M.D., Ph.D., to Chief Medical Officer
Catabasis Pharmaceuticals Appoints Joanne M. Donovan, M.D., Ph.D., to Chief Medical Officer
HSMN NewsFeed - 28 Jul 2011
Ramona M. Lloyd, Ph.D., RAC, Joins Omthera Pharmaceuticals as Vice President Regulatory Affairs
Ramona M. Lloyd, Ph.D., RAC, Joins Omthera Pharmaceuticals as Vice President Regulatory Affairs
HSMN NewsFeed - 14 Mar 2011
Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding Led by New Enterprise Associates
Omthera Pharmaceuticals Raises $33.9 Million in Series B Funding Led by New Enterprise Associates
HSMN NewsFeed - 2 Feb 2011
Amarin Corporation Appoints Industry Veteran Paul E. Huff as Chief Commercial Officer
Amarin Corporation Appoints Industry Veteran Paul E. Huff as Chief Commercial Officer
HSMN NewsFeed - 8 Dec 2010
Catabasis Pharmaceuticals Secures $14.5 Million Second Tranche in Series A Financing
Catabasis Pharmaceuticals Secures $14.5 Million Second Tranche in Series A Financing
HSMN NewsFeed - 14 Oct 2010
Catabasis Pharmaceuticals Appoints Michael Curtis, Ph.D., as Vice President, Product Development
Catabasis Pharmaceuticals Appoints Michael Curtis, Ph.D., as Vice President, Product Development
HSMN NewsFeed - 9 Feb 2010
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
Sequenom Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostic Test
HSMN NewsFeed - 2 Dec 2009
Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
HSMN NewsFeed - 15 Apr 2009
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
HSMN NewsFeed - 29 May 2008
Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials
Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials
HSMN NewsFeed - 10 Sep 2007
Resolvyx Pharmaceuticals Hires James Nichols as EVP of Corporate Development
Resolvyx Pharmaceuticals Hires James Nichols as EVP of Corporate Development
HSMN NewsFeed - 27 Jul 2007
Reliant Pharmaceuticals Names Fred Craves, Ph.D. as Chairman of the Board of Directors
Reliant Pharmaceuticals Names Fred Craves, Ph.D. as Chairman of the Board of Directors
HSMN NewsFeed - 16 Jan 2007
Reliant Pharmaceuticals Names Bradley T. Sheares, Ph.D. Chief Executive Officer
Reliant Pharmaceuticals Names Bradley T. Sheares, Ph.D. Chief Executive Officer
HSMN NewsFeed - 11 Nov 2006
Bausch & Lomb Showcases New Technologies at American Academy of Ophthalmology Annual Meeting
Bausch & Lomb Showcases New Technologies at American Academy of Ophthalmology Annual Meeting
Additional items found! 10
Members Archive contains
10 additional stories matching:
omega-3
(Password required)
omega-3
(Password required)
